Core Viewpoint - United Airlines has shown an 8.7% increase in share price since the last earnings report, outperforming the S&P 500, raising questions about the sustainability of this trend leading up to the next earnings release [1] Financial Performance - In Q2 2025, United Airlines reported adjusted earnings per share (EPS) of $3.87, beating the Zacks Consensus Estimate by $0.01, but reflecting a 6.5% decline year-over-year [2] - Operating revenues reached $15.2 billion, falling short of the Zacks Consensus Estimate of $15.4 billion, but showing a 1.7% year-over-year increase [3] - Passenger revenues, which constituted 90.8% of total revenues, increased by 1.1% year-over-year to $13.8 billion, with 46,186 passengers transported, up 4.1% year-over-year [3][4] - Cargo revenues grew by 3.8% year-over-year to $430 million, while revenues from other sources rose by 8.8% year-over-year to $970 million [3][4] Operational Metrics - Airline traffic, measured in revenue passenger miles, increased by 4.5%, while capacity, measured in available seat miles, expanded by 5.9%, leading to a consolidated load factor decline of 1.1 points year-over-year to 83.1% [6] - Consolidated passenger revenue per available seat mile decreased by 4.5% year-over-year, and total revenue per available seat mile fell by 4% year-over-year [7] Cost and Expenses - Operating expenses increased by 6.5% year-over-year to $13.9 billion, with consolidated unit cost per available seat mile (excluding certain expenses) rising by 2.2% year-over-year to 12.36 cents [8] Cash Flow and Debt - United Airlines ended Q2 with cash and cash equivalents of $9.35 billion, slightly down from $9.37 billion in the previous quarter, while long-term debt decreased from $24.4 billion to $20.8 billion [9] - The company repurchased $0.2 billion of shares in Q2 2025 and generated $1.13 billion in free cash flow during the quarter [9] Future Outlook - United Airlines anticipates reduced geopolitical and macroeconomic uncertainty in the second half of 2025, with a projected adjusted EPS for Q3 2025 between $2.25 and $2.75 [10] - For the full year 2025, the company expects adjusted EPS between $9.00 and $11.00, a revision from previous guidance [11] Market Position - United Airlines has a VGM Score of A, indicating strong value, but a lower momentum score of D, suggesting mixed performance in different investment strategies [13] - The stock currently holds a Zacks Rank 3 (Hold), indicating expectations for an in-line return in the coming months [14]

Core Insights - Rivian Automotive (RIVN) reported a second-quarter 2025 loss of 80 cents per share, missing the Zacks Consensus Estimate of a loss of 65 cents per share but showing improvement from a loss of $1.21 in the same period last year. Revenues reached $1.3 billion, exceeding the Zacks Consensus Estimate of $1.26 billion and reflecting a year-over-year increase of 12.5% driven by growth in software and services revenues [1][9]. Q2 Highlights - Total production for Rivian in the reported quarter was 5,979 units, a decrease from 9,612 units in the year-ago quarter. The company delivered 10,661 units, down from 13,790 units a year ago [2]. Financial Performance - The total gross loss for the quarter was $206 million, an improvement from a gross loss of $451 million in the prior-year quarter. The gross margin for the reported quarter was negative 16%. Adjusted operating expenses totaled $681 million, slightly up from $676 million in the prior-year quarter. Adjusted loss before interest, taxes, depreciation, and amortization was $667 million, significantly better than the $857 million loss in Q2 2024 [3]. Cash Flow and Expenditures - Net cash provided by operating activities for the quarter was $64 million, compared to $754 million used in the prior-year quarter. Capital expenditures for Q2 were $462 million, up from $283 million in the same period last year. Free cash outflow for the quarter was $398 million [4]. Segment Performance - The Automotive segment generated revenues of $927 million, down 13.7% year over year, primarily due to lower sales of first-generation R1 vehicles and vans. The total cost of revenues for this segment was $1,262 million, down 16.7% year over year, resulting in a gross loss of $335 million compared to a gross loss of $441 million in the prior-year quarter [5]. - The Software and Services segment recorded revenues of $376 million, more than tripling year over year, driven by new vehicle electrical architecture, software development services, and increased repair and maintenance services. The total cost of revenues for this segment was $247 million, more than doubling year over year, leading to a gross profit of $129 million compared to a loss of $10 million in the same quarter of 2024 [6]. Financial Position - As of June 30, 2025, Rivian had $4.81 billion in cash and cash equivalents, down from $5.29 billion as of December 31, 2024. Long-term debt stood at $4,436 million, slightly down from $4,441 million at the end of 2024 [7]. 2025 Guidance - Rivian updated its guidance for the full year 2025, expecting to deliver between 40,000 to 46,000 vehicles. The adjusted EBITDA loss is projected to be between $2 billion and $2.25 billion, wider than the previous guidance of a loss of $1.7 billion to $1.9 billion. Capital expenditure expectations remain between $1.8 billion and $1.9 billion [8].

Core Insights - Amcor Plc reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of 20 cents, missing the Zacks Consensus Estimate of 21 cents, and down from 21 cents in the same quarter of the previous year [1] - Total revenues for the quarter were $5.08 billion, below the Zacks Consensus Estimate of $5.17 billion, but up 43.8% year over year [2] - The company experienced a gross margin contraction to 17.6% from 21.3% in the prior-year quarter due to a significant increase in the cost of sales [3] Financial Performance - Adjusted operating income for the quarter was $611 million, reflecting a 34.6% increase from $454 million in the prior-year quarter, with an adjusted operating margin of 12% compared to 12.8% previously [4] - Adjusted EBITDA for the quarter was $789 million, up from $550 million in the fourth quarter of fiscal 2024, with an adjusted EBITDA margin of 15.5% [5] - The cost of sales rose 50.6% year over year to $4.19 billion, while gross profit increased 18.7% to $895 million [3] Segment Performance - The Global Flexible Packaging Solutions segment reported net sales of $3.21 billion, a 19.3% increase year over year, with adjusted operating income rising 11.7% to $450 million [7] - The Global Rigid Packaging Solutions segment saw net sales skyrocket 121.1% to $1.88 billion, with adjusted operating income up 172% to $204 million, driven by acquired sales [8] Cash Flow and Balance Sheet - As of the end of fiscal 2025, Amcor had $827 million in cash and cash equivalents, an increase from $588 million at the end of fiscal 2024, and generated $1.39 billion in cash from operating activities [9] - The company reported an adjusted free cash outflow of $926 million for fiscal 2025, slightly improved from $952 million in the previous fiscal year [9] Fiscal Year Overview - For fiscal 2025, Amcor reported an adjusted EPS of 71 cents, missing the Zacks Consensus Estimate of 73 cents, but improved 1% year over year [11] - Total revenues for fiscal 2025 increased 9% year over year to $15.01 billion, exceeding the consensus estimate of $14.88 billion [12] Future Guidance - Amcor expects adjusted EPS for fiscal 2026 to be in the range of 80-83 cents and projects free cash flow of $1.8-1.9 billion [13] Stock Performance - Over the past year, Amcor shares have declined by 2%, compared to a 3.7% drop in the industry [14]

Core Insights - H&R Block, Inc. (HRB) reported mixed results for Q4 of fiscal 2025, with earnings missing estimates while revenues exceeded expectations [1][9] - Adjusted earnings per share (EPS) were $2.27, falling short of the Zacks Consensus Estimate by 19.2% but showing a year-over-year increase of 20.1% [1][9] - Total revenues reached $1.11 billion, surpassing the Zacks Consensus Estimate by 3.7% and increasing 4.6% year over year [1][9] Financial Performance - Revenues from U.S. tax preparation and related services amounted to $975.5 million, reflecting a 5% year-over-year growth [5] - Financial services revenues totaled $16.1 million, down 14.6% year over year [5] - International revenues increased by 1.3% to $89.9 million, while Wave revenues surged 14.4% to $29.54 million [5] Balance Sheet and Cash Flow - At the end of fiscal 2025, H&R Block had cash and cash equivalents of $210.28 million and total cash of $983.28 million [6] - Long-term debt decreased to $1.14 billion from $1.49 billion in the previous year [6] - The company utilized $680.89 million in cash for operating activities, with capital expenditures of $82.03 million [6] Fiscal 2026 Outlook - For fiscal 2026, H&R Block anticipates revenues between $3.875 billion and $3.895 billion, with the Zacks Consensus Estimate at $3.72 billion [7] - The company expects adjusted EPS in the range of $4.85 to $5.00, while the Zacks Consensus Estimate stands at $5.22 [7] - Projected EBITDA is between $1.015 billion and $1.035 billion, with an expected effective tax rate of 25% [7] Stock Performance - H&R Block shares have declined by 9.5% over the past year, outperforming the industry average decline of 12.8% [4]

Group 1 - Madison Square Garden (MSGS) reported revenue of $203.96 million for the quarter ended June 2025, a decrease of 10.3% year-over-year, with an EPS of -$0.07 compared to $1.06 in the same quarter last year [1] - The reported revenue exceeded the Zacks Consensus Estimate of $165.69 million by 23.1%, and the EPS surprised by 83.33% against the consensus estimate of -$0.42 [1] - The stock has returned -4.3% over the past month, underperforming the Zacks S&P 500 composite's +3.1% change, and currently holds a Zacks Rank 5 (Strong Sell) [3] Group 2 - Total revenues from event-related contracts were $140.32 million, surpassing the average estimate of $88.37 million, but reflecting a year-over-year decline of 7.8% [4] - League distributions and other revenues totaled $3.99 million, below the average estimate of $5.08 million, marking a significant year-over-year decrease of 66.8% [4] - Sponsorship, signage, and suite licenses generated $31.88 million, slightly above the estimated $29.22 million, but down 8.2% compared to the previous year [4] - Media rights revenues were reported at $27.77 million, slightly below the estimated $28.38 million, with a year-over-year decline of 2.3% [4]

Brinker International, Inc. EAT will release earnings results for the fourth quarter before the opening bell on Wednesday, Aug. 13. Analysts expect the Dallas, Texas-based company to report quarterly earnings at $2.47 per share, versus $1.61 per share in the year-ago period. Brinker International projects to report quarterly revenue of $1.44 billion, compared to $1.21 billion a year earlier, according to data from Benzinga Pro. Benzinga readers can access the latest analyst ratings on the Analyst Stock Rati ...

Core Insights - Cardinal Health, Inc. reported fourth-quarter fiscal 2025 adjusted earnings per share (EPS) of $2.08, exceeding the Zacks Consensus Estimate of $2.03 by 2.5% and reflecting a 13% year-over-year improvement [1] - The company raised its fiscal 2026 earnings guidance, anticipating adjusted EPS between $9.30 and $9.50, up from a previous outlook of $9.10-$9.30 [9] Revenue Details - Total sales for the quarter were flat year-over-year at $60.2 billion, missing the Zacks Consensus Estimate by 0.8% [2] Segmental Analysis - **Pharmaceutical and Specialty Solutions**: Revenues were nearly flat at $55.4 billion year-over-year, but excluding the impact of a customer contract expiration, sales increased by 22% [3] - **Pharmaceutical Profit**: Totaled $535 million, an 11% increase from the previous year, driven by growth in brand and specialty products [4] - **Global Medical Products and Distribution**: Revenues reached $3.2 billion, up 3% year-over-year, with profits increasing from $47 million to $70 million [4] - **Other Segment**: Sales grew by 37% year-over-year to $1.6 billion, with profits rising 44% to $160 million [5] Margin Analysis - Gross profit increased by 17% year-over-year to $2.2 billion, with a gross margin of 3.7%, expanding approximately 50 basis points [6] Financial Update - The company ended the quarter with cash and cash equivalents of $3.33 billion, down from $3.81 billion in the previous quarter, while net cash provided by operating activities was $2.91 billion compared to a net cash usage of $27 million in the prior year [8] 2026 Outlook - The company expects revenues from the Pharmaceutical segment to grow by 11-13% year-over-year, with segmental profit also anticipated to increase by 11-13% [9] - Medical segment revenues are estimated to grow by 2-4%, while the Other segment is projected to see revenue growth of 26-28% [10] Conclusion - Cardinal Health's fourth-quarter results showed mixed performance, with earnings exceeding estimates but revenues falling short. Profit growth was observed across all segments, particularly in Pharmaceutical and Specialty Solutions, Global Medical Products, and the Other segment [11]

Core Insights - ANI Pharmaceuticals reported $211.37 million in revenue for Q2 2025, a 53.1% year-over-year increase, with an EPS of $1.80 compared to $1.02 a year ago, exceeding Zacks Consensus Estimates [1] - The company achieved a revenue surprise of +12.22% and an EPS surprise of +30.43% compared to analyst expectations [1] Revenue Breakdown - Net Revenues from Rare Disease and Brands - Cortrophin Gel: $81.65 million, surpassing the estimated $65.23 million [4] - Net Revenues from Rare Disease and Brands - ILUVIEN and YUTIQ: $22.32 million, slightly above the $21.74 million estimate [4] - Net Revenues from Generic pharmaceutical products: $90.3 million, exceeding the $85.32 million estimate [4] - Total Net Revenues from Rare Disease: $103.96 million, compared to the estimated $86.96 million [4] - Total Net Revenues from Generics and Other: $94.21 million, slightly below the $96.49 million estimate [4] - Net Revenues from Royalties and other pharmaceutical services: $3.92 million, significantly below the estimated $10.46 million [4] - Total Net Revenues from Rare Disease and Brands: $117.16 million, far exceeding the estimated $94.3 million, representing a year-over-year change of +138.2% [4] Stock Performance - ANI's shares have returned +25.4% over the past month, outperforming the Zacks S&P 500 composite's +2.7% change [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating potential performance in line with the broader market [3]

Core Viewpoint - Chime Financial's stock experienced a significant drop following a strong earnings report, as investors took profits after a substantial increase post-IPO [1][2]. Financial Performance - In Q2, Chime reported a revenue increase of 37% to $528 million, with payments revenue growing by 19% and platform-related revenue soaring by 113% [3]. - The company recorded a net loss of $923 million, primarily due to a one-time stock-based compensation expense from its IPO; without this, Chime would have reported a profit of $5 million and an adjusted EBITDA of $16 million [4]. - Management provided a full-year revenue forecast for 2025 between $2.135 billion and $2.155 billion, along with adjusted EBITDA expectations of $84 million to $94 million, surpassing analyst estimates [5]. Market Reaction - Despite strong earnings, the stock's valuation remains high, trading at 5 times this year's revenue guidance and over 110 times this year's EBITDA guidance, indicating that while not excessively valued for a high-growth company, it is not considered cheap either [7]. - The earnings report is viewed as a strong start to Chime's public life, but the company will need to continue demonstrating its growth potential to maintain investor confidence [8].

Core Insights - Akamai Technologies, Inc. (AKAM) reported strong second-quarter 2025 results, with both revenue and net income exceeding the Zacks Consensus Estimate [1][2] Financial Performance - GAAP net income decreased to $103.6 million or 71 cents per share from $131.7 million or 86 cents per share year-over-year, impacted by high operating expenses [2] - Non-GAAP net income increased to $251.4 million or $1.73 per share compared to $242.6 million or $1.58 per share a year ago, beating the Zacks Consensus Estimate by 18 cents [2] - Quarterly net sales reached $1.04 billion, a 7% increase from $979.6 million in the prior year, driven by strong momentum in the Security and Compute verticals, surpassing the Zacks Consensus Estimate of $1.02 billion [3] Revenue Breakdown - Security Technology Group revenues were $551.9 million, up 11% from $498.7 million year-over-year, primarily due to demand for Guardicore Segmentation Solution and API security solutions [4] - Delivery segment revenues fell to $320 million from $329.4 million year-over-year, but exceeded the estimate of $301.6 million [5] - Compute segment revenues increased to $171.4 million from $151.5 million in the prior year, driven by demand for cloud infrastructure services, beating the estimate of $165.7 million [5] Regional Performance - Net sales from the United States were $527.6 million, a 4% year-over-year increase, while international revenues totaled $515.9 million, up from $470.8 million in the previous year [6] Operating Expenses and Margins - Total operating expenses rose to $892 million from $831.6 million year-over-year, while non-GAAP income from operations improved to $308.6 million from $281.5 million, with margins of 30% and 29% respectively [7] - Adjusted EBITDA increased to $444.4 million from $408.9 million in the prior year [7] Cash Flow and Share Repurchase - Akamai generated $459.1 million in cash from operating activities compared to $430.9 million in the prior year [8] - As of June 30, 2025, the company had $850.3 million in cash and cash equivalents and repurchased approximately 3.9 million shares for around $300 million [9] Future Outlook - For Q3 2025, Akamai expects revenues between $1.03 billion and $1.05 billion, with a non-GAAP operating margin projected at 28% [10] - For the full year 2025, revenues are expected to be in the range of $4.135 billion to $4.2 billion, with non-GAAP earnings projected between $6.60 and $6.80 per share [11]